# Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

> **NCT03295981** · PHASE3 · RECRUITING · sponsor: **St. Louis University** · enrollment: 120 (estimated)

## Conditions studied

- Giant Cell Tumor of Bone

## Interventions

- **DRUG:** Zoledronic Acid

## Key facts

- **NCT ID:** NCT03295981
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-05-03
- **Primary completion:** 2027-01
- **Final completion:** 2028-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03295981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03295981, "Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03295981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*